본문 바로가기
KERD
논문KCI 등재

주의력결핍 과잉행동장애에서 도파민 운반체 유전자의 10-Repeat Allele Homozygosity와 [¹²³I]IPT SPECT로 측정한 도파민 운반체 밀도가 Methylphenidate 치료 반응에 미치는 영향

Effect of Homozygosity for 10-Repeat Allele at Dopamine Transporter Gene and Dopamine Transporter Density Assessed with [123I]IPT SPECT on Response to Methylphenidate Treatment in Attention

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류정신과학

초록

Abstract

Objectives:The symptoms of attention-deficit/hyperactivity disorder (ADHD) can be treated with methylphenidate, a potent blocker of the dopamine transporter (DAT). The homozygosity of the 10-repeat allele at dopamine transporter gene (DAT1) seems to be associated with a poor response to methylphenidate (MPH) in children with ADHD. In present study, we investigated association between DAT density using I-123N-(3-iodopropen-2-yl)-2β-carbomethoxy-3beta-(4-chlorophenyl)tropane ([123I]IPT SPECT) and the homozygosity for 10-repeat allele at DAT1, and response to MPH in children with ADHD. Methods:Eleven drug-naive children with ADHD were included in the study and treated with MPH for about 8 weeks. After the genotyping and SPECT were performed, we compared DAT density between ADHD children with and without the homozygosity for the 10-repeat allele at DAT1 and investigated correlation between the homozygosity for the 10-repeat allele and response to MPH. Results:ADHD children with 10/10 genotype (n=7) had a significantly higher DAT density in basal ganglia than the children without 10/10 genotype (n=4)(Right:z=-2.65, p=0.008;Left:z=-2.65, p=0.008). We found that while only 28.6% (2/7) of the subject with 10/10 genotype showed good response (≥50% improvement) to MPH treatment, 100% (4/4) of the subjects without 10/10 genotype showed good response to MPH treatment (χ2 test:F=5.238, df=1, p=0.022). Conclusion:Our findings support an association between homozygosity for the 10-repeat allele at DAT1 and the DAT density assessed in vivo and correlation between the homozygosity for the 10-repeat allele and poor response to MPH. (J Korean Neuropsychiatr Assoc 2004;43(2):151-158)

참고문헌 (25)

  1. "Critique of current diagnostic criteria for attention deificithyepractivity disorder:clinical and research implications", 11, pp.343~352 (1990)
  2. "Diagnostic and Statistical Manualfor Mental Disorders" (1994), American PsychiatricAssociation Press
  3. "파탄적 행동장애의 유병률에 대한 연구", 41, pp.141~149 (1991)
  4. "Correlates,associated impairmentsand patterns of service utilization of children with attention deificitdisorder:findings from the Ontario Child Health Study", 30, pp.205~217 (1989)
  5. "소아정신과와 소아과 외래환자의 과잉행동에관한 연구", 23, pp.51~57 (1980)
  6. "Adultoutcome of hyperactive boys", pp.565~576
  7. "Pharmacotherapy of attention-deficit hyperactivity disorder acrossthe life cycle", 35, pp.409~432 (1996)
  8. "distribution and association with lamininsand developmental switches", pp.879~891
  9. "Associationstudy of a dopamine transporter polymorphism and attentiondeficit hyperactivity disorder in UK and Turkish samples", 6, pp.425~428 (2001)
  10. "Association and linkage of the dopamine transportergene and attention-deficit hyperactivity disorder in children:heterogeneity owing to diagnostic subtype and severity", 63, pp.1767~1776 (1998)
  11. "Association of attention-deficit disorder and the dopaminetransporter gene", 56, pp.993~998 (1995)
  12. "Association of the dopamine transportergene(DAT1)with poor methylphenidate response", 38, pp.1474~1477 (1999)
  13. "Dopamine transporter gene and response to methylphenidate inattention-deficit", hyperactivity disorder, 2002, pp.12, 497~499
  14. "TheVNTR polymorphism of the human dopamine transporter(DAT1)gene affects gene expression", 1, pp.152~156 (2001)
  15. "Dopamine transporter gene,response to methylphenidate and cerebralblood flow in attention-deficit", hyperactivity disorder:a pilot study, 2003, pp.48, 87~89
  16. IPTSPET in children with attention deficit hyperactivity disorder, , 2003, 306~311
  17. IPT SPECT로측정한 기저 신경절 dopamine transporter density, , 2003, 61~68
  18. "Schedule for Affective Disorders and Schizophrenia for School-AgeChildren-Present and Life Time Version(K-SADS-PL)initial reliabilityand validity data", 36, pp.980~988 (1997)
  19. "The reliability and validity of Kiddie-Schedule for Affective Disordersand Schizophrenia - Present and Lifetime Version - Korean Version(K-SADS-PL-K)", 45, pp.81~89 (2004)
  20. "ADHD RatingScale-IV: Checklists, Norms, and Clinical Interpretation" (1998), Guilford Press
  21. "한국어판 부모,교사ADHD 평가 척도의 신뢰도와 타당도 연구", 41, pp.283~289 (2002)
  22. "maps to chromosome5p15", pp.3 1104~1106
  23. "A method for attenuation correction in ratio nuclidecomputed tomography", 25, pp.638~643 (1978)
  24. "Genotype influences in vivo dopamine transporter availability inhuman striatum", 22, pp.133~139 (2000)
  25. "Prediction of dopamine transporter binding availability bygenotype:a preliminary report", 157, pp.1700~1703 (2000)

관련 논문AI추천

주의력결핍 과잉행동장애 아동에서 methylphenidate 투여 전후 [123I]IPT SPECT로 측정한 기저 신경절 dopamine transporter density김찬형, 남궁기, 유영훈, 이종두, 천근아대한신경정신의학회 · 신경정신의학2003 · 제42권 제1호한국인 주의력결핍 과잉행동장애 아동에서 도파민 D4 수용체 유전자의 Variable Number of Tandem Repeats (VNTR) 다형성과 Methylphenidate 치료 반응간의 연관성김붕년, 김재원, 신민섭, 조수철, 천근아, 홍강의, 황준원대한신경정신의학회 · 신경정신의학2005 · 제44권 제6호한국인에서 주의력결핍 과잉운동장애 환자와 도파민 수송체 유전자(DAT1) 다형성의 연관성 연구노경선, 신동원, 오강섭, 이민수대한신경정신의학회 · 신경정신의학2002 · 제41권 제4호No Association between the Response to Methylphenidate and DRD4 Gene Polymorphism in Korean Attention Deficit Hyperactivity Disorder: A Case Control Study박우성, 백기청, 임명호, 지현수대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2013 · 제11권 제1호주의력결핍과잉행동장애에서 Alpha-2A-Adrenergic 수용체 유전자와 Methylphenidate 반응과의 연관성에 대한 연구김붕년, 김재원, 김효진, 박민현, 박은진, 박진우, 신민섭, 조수철, 홍순범대한신경정신의학회 · 신경정신의학2011 · 제50권 제5호한국인 주의력결핍과잉운동장애 아동의 Catechol-O-Methyltransferase 유전자 다형성이철, 김정진, 성양숙, 이수정, 임태식, 한상익대한신경정신의학회 · 신경정신의학2002 · 제41권 제2호

이 간행물의 다른 논문 (14건)